Dr. Brian W. Loggie
Surgical OncologistDr. Brian Loggie ventured into uncharted waters when in the 1990s he pioneered a mesothelioma treatment often referred to as heated intraperitoneal chemotherapy or HIPEC. Dr. Loggie retired in January 2022.
-
Expertise:Cytoreductive Surgery
HIPEC -
Speciality:Surgical Oncology -
Gender:Male -
Language:English -
Primary Location:CHI Health Creighton University Medical Center
Get to Know Dr. Brian Loggie
Early in Dr. Brian Loggie’s medical career, he helped develop a new cancer treatment that combined surgery with heated chemotherapy drugs. The benefits were immediate, and the heat made the drugs more effective in killing the various kinds of cancer. As a result, the procedure is now widely used. Dr. Loggie retired in January 2022.
He earned his medical degree from McGill University in Montreal, Canada. His post-graduate training included an internship with the Montreal General Hospital Department of Surgery, where he later did his residency.
Dr. Loggie worked at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. He then moved to the Creighton University School of Medicine.
Specialties of Dr. Brian Loggie
- Surgical oncology
- Peritoneal mesothelioma
- Hyperthermic intraperitoneal chemotherapy
- Research
Dr. Brian Loggie’s Experience and Medical Education
- Creighton University School of Medicine
- Wake Forest Baptist Medical Center
- University of Illinois at Chicago (Fellowship)
- Montreal General Hospital (Residency)
- McGill University Faculty of Medicine (M.D.)
Awards and Certifications for Dr. Brian Loggie
- Best Doctors in America (2001 to present)
- Castle Connolly’s America’s Top Doctors (2011)
- Magis Award, Creighton University (2010)
Publications of Dr. Brian Loggie
Dr. Loggie has authored or co-authored numerous articles and papers detailing treatments he has developed, many documenting mesothelioma research. Loggie’s articles appear in journals such as the Annals of Surgical Oncology and the World Journal of Surgical Oncology.
- Larsen, N.K. et al. (2020, November). Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary. Gynecologic Oncology Reports.
- Govaerts, K. et al. (2020, February 28). Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. European Journal of Surgical Oncology.
His publications focus on malignant peritoneal mesothelioma, a rare form of the disease representing just 20% of all cases. It grows in the abdominal cavity lining and is directly related to the inhalation or ingestion of asbestos.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
